Fulcrum Therapeutics Names Robert Gould As Interim CEO After CEO Bryan Stuart Departs

RTTNews | 763日前
Fulcrum Therapeutics Names Robert Gould As Interim CEO After CEO Bryan Stuart Departs

(RTTNews) - Biopharmaceutical company Fulcrum Therapeutics, Inc. (FULC) announced Wednesday that Robert Gould, former president and founding chief executive officer, has been appointed as interim CEO, effective January 3, 2023. He is also a current member of the Board of Directors.

Gould succeeds Bryan Stuart, who departs to pursue other opportunities. Fulcrum's Board of Directors has initiated a search for a permanent CEO.

Gould has over 35 years of biopharmaceutical industry and management experience. He served as founding president and CEO of Fulcrum from 2016 to 2021, after which he remained a member of the Board of Directors. Before Fulcrum, he served as president and CEO of Epizyme from 2010 to 2015.

Before that, Gould spent more than 20 years at Merck in leadership positions of increasing responsibility, culminating in the role of vice president, licensing, and external research.

Meanwhile, Stuart was serving as president and CEO of Fulcrum since March 2021. He joined Fulcrum as chief operating officer in 2018. Prior to joining Fulcrum, Bryan was president and CEO of Yarra Therapeutics.

read more
Swiss Market Ends On Firm Note

Swiss Market Ends On Firm Note

After struggling for direction till an hour before noon, the Switzerland market started to climb higher on Wednesday, as investors pickup stocks, reacting to earnings updates.
RTTNews | 6時11分前
U.S. Services Index Unexpectedly Indicates Modestly Slower Growth In January

U.S. Services Index Unexpectedly Indicates Modestly Slower Growth In January

Service sector growth in the U.S. unexpectedly slowed modestly in the month of January, according to a report released by the Institute for Supply Management on Wednesday. The ISM said its services PMI dipped to 52.8 in January from a revised 54.0 in December. While a reading above 50 still indicates growth, economists had expected the index to inch up to 54.3.
RTTNews | 9時29分前
U.S. Trade Deficit Spikes To Over Two-Year High In December

U.S. Trade Deficit Spikes To Over Two-Year High In December

A report released by the Commerce Department on Wednesday showed the U.S. trade deficit widened significantly in December, as imports surged and exports plunged. The Commerce Department said the trade deficit spiked to $98.4 billion in December from a revised $78.9 billion in November. Economists had expected the trade deficit to jump to $96.6 billion.
RTTNews | 9時59分前
U.S. Private Sector Job Growth Exceeds Estimates In January

U.S. Private Sector Job Growth Exceeds Estimates In January

Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by more than expected in the month of January. ADP said private sector employment climbed by 183,000 jobs in January after rising by an upwardly revised 176,000 jobs in December. Economists had expected private sector employment to rise by 150,000 jobs.
RTTNews | 10時48分前
GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares

GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, after the British drug maker reported Wednesday a higher fourth-quarter results and issued positive outlook for fiscal 2025. The company further raised its sales view for fiscal 2031, and announced dividends and 2 billion pounds share buyback programme.
RTTNews | 10時49分前